Trim 15-25% of SPCX; retain 75-85% benchmark weight per binding lessons; $134.50 hard stop, $155.88 is exit target not stop
SPCX Underweight is the synthesis between Aggressive analyst (correct on asymmetry and valuation math but wrong on runway ignoring $85B Q2 raise and wrong on re-entry assuming clean $113 flush) and Conservative analyst (correct on institutional floor and stop-logic inversion but underweights Starship execution deterioration). Hold is structurally alpha-negative given 88x forward P/E, declining MACD histogram, lower-high divergence at $146-147 supply zone, three declining-volume rejections (167M→116M→119M→55M), and hawkish macro overlay with 89% no-cut odds. Full Sell is contraindicated per binding lessons given audited operational inflection (revenue +92% YoY, gross margin 55.3%, EBITDA -$1.16B to +$2.96B, OCF -$376M to +$2.42B, $93.5B-$100B cash fortress) and institutional floor that has absorbed three tests of $108.
| Position | Action |
|---|---|
| Core residual position | Half-normal weight given 5.8% daily ATR volatility |
| Trim magnitude | 15-25% trim (75-85% benchmark retention) - smaller end of historical trim range per binding 8/25, 8/26, 8/27 lessons |
| Execution approach | Scale sales into $146-148 across 2-3 tranches - avoid single-shot at $141 into 200 SMA test where institutional bid most likely to defend |
| Residual longs exit target | $155.88 (upper Bollinger band) - NOT a stop loss, this is the exit target for any remaining core position |
The bull case rests on accelerating fundamentals (91.9% YoY revenue growth, $4B EBITDA swing, $93.5B cash) that contradict bear concerns about valuation and cash burn, combined with a technically coiled setup at a major long-term pivot backed by the strongest coalition of institutional capital in commercial space.
| Indicator | Value | Signal |
|---|---|---|
| Close | 141.50 | neutral |
| 10 EMA | 138.51 | bullish |
| 50 SMA | 137.56 | bearish |
| 200 SMA | 141.38 | neutral |
| RSI (14) | 54.84 | bullish |
| MACD | 2.44 | bullish |
| MACD Signal | 1.58 | bullish |
| MACD Histogram | 0.86 | bullish |
| Bollinger Middle | 134.54 | neutral |
| Bollinger Upper | 155.88 | bearish |
| Bollinger Lower | 113.19 | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Flush to $113 where risk/reward finally flips
Then: Consider reload at $113 flush - but no pre-commitment as institutional bid likely to compress downside
The $85.68B equity raise created a fortress balance sheet that transforms the 'free cash flow problem' from a constraint into a deliberate strategic choice to self-fund a multi-year capex super-cycle
↩ rebuts: “Bear's concern about cash burn leading to insolvency”
EV: Buy target: $146 (resistance reclaim), $155.88 (Bollinger upper); Stop loss: ~$129 (close minus 1.5× ATR); Accumulation zone: $134–$138
SPCX is a capital-consuming machine trading at venture capital multiples with no path to self-funding, deteriorating execution odds, and a 6-quarter fuse before mandatory dilution — the risk/reward is 2:1 against buyers at current levels.
EV: $113 (Bollinger lower band, 20% downside from $141.50) · concedes: EBITDA inflected from negative $1.16B to positive $2.96B in Q2 — the swing is real; One quarter of operating leverage is possible (though not confirmed as trend); Alphabet's $94B stake is real capital at stake, even if legacy; Musk has succeeded before (Tesla, PayPal) — though track record is mixed, not uniformly bearish
→ vs neutral: Framing 'wait for confirmation above 143 or below 134' assumes symmetric squeeze resolution when data shows asymmetric breakdown probability; 'coiled at major pivot' is a coin flip masquerading as high-probability setup
→ vs conservative: 'Meaningful Q2 inflection' is one green data point used to dismiss secular bearish setup; anchoring to old news (Alphabet, Morgan Stanley, Nvidia) while new information is brutal (Starship probability collapse)
→ vs conservative: 'Trim 10-15% and hold core' is worst of both worlds—transaction costs paid but bulk of exposure retained; 'hedge with puts' ignores that 88x earnings with elevated IV makes hedging prohibitively expensive
→ vs conservative: Balance sheet runway of 5-6 quarters before forced dilutive raise is structurally incompatible with 'core holding' approach at 88x forward earnings
→ vs neutral: The contingency plan IS the trade—when asymmetric downside, deteriorating catalyst probability, and balance sheet runway measured in quarters, the aggressive move is to step aside now
| ATR | 8.23 | neutral |
Support: 138.51 · 137.56 · 134.54 · 134 · 113.19 | Resistance: 155.88 · 146.15 · 141.38
SPCX has recovered ~33% from its July 31 low of 108.37 after a parabolic June spike to 225.64, and is now testing the 200 SMA at 141.38 with price at 141.50. The 10 EMA (138.51) has crossed above the 50 SMA (137.56) for the first bullish signal since June, MACD is expanding positively with histogram at its highest since June 18, and RSI at 54.84 remains in neutral territory with room to run. Bollinger Bands have compressed from ~80 points to ~42 points, signaling a high-probability breakout setup expected within 5–10 sessions. The recommended action is HOLD, with breakout trigger above 143 on volume >70M and stop/loss at 129.15 (ATR-based) or 134.50 zone.
Market Cap
$1,865.22B
Forward P/E
88.36x
P/B Ratio
14.65x
EPS (TTM)
-$1.10
Forward EPS
$1.60
52-Week High
$225.64
52-Week Low
$104.83
50-Day MA
$138.57
200-Day MA
$141.38
Book Value/Share
$9.66
Q2 2026 Revenue
$7.81B
Q1 2026 Revenue
$4.69B
Q1 2025 Revenue
$4.07B
Q2 2025 Revenue
$4.07B
Q2 2026 Gross Profit
$4.32B
Q2 2026 Operating Income
-$141M
Q2 2026 EBITDA
$2.96B
Q2 2026 Net Income
-$541M
Q1 2026 Net Income
-$4.28B
Operating Margin TTM
-1.8%
Profit Margin TTM
-35.7%
Q2 2026 R&D
$3.55B
Q2 2025 R&D
$1.96B
Q2 2026 SG&A
$912M
Q2 2025 SG&A
$606M
Q2 2026 Interest Expense
$629M
Q2 2026 Interest Income
$340M
Total Assets Q2 2026
$192.77B
Total Assets Q1 2026
$102.09B
Cash & Equivalents Q2 2026
$93.52B
Cash & Equivalents Q1 2026
$15.85B
Short-Term Investments Q2 2026
$6.49B
Short-Term Investments Q1 2026
$7.82B
Total Debt Q2 2026
$39.71B
Total Debt Q1 2026
$30.60B
Stockholders' Equity Q2 2026
$127.22B
Stockholders' Equity Q1 2026
$41.58B
Total Liabilities Q2 2026
$65.55B
Total Liabilities Q1 2026
$60.51B
Working Capital Q2 2026
$86.93B
Working Capital Q1 2026
$5.30B
Net PPE Q2 2026
$66.85B
Net PPE Q1 2026
$55.06B
Current Ratio Q2 2026
5.12
Current Ratio Q1 2026
1.22
Retained Earnings Q2 2026
-$41.85B
Retained Earnings Q1 2026
-$41.31B
Common Stock Issuance Q2 2026
$85.68B
Operating Cash Flow Q2 2026
+$2.42B
Operating Cash Flow Q1 2026
+$1.05B
Operating Cash Flow Q2 2025
-$376M
Operating Cash Flow Q1 2025
+$727M
Free Cash Flow Q2 2026
-$16.82B
Free Cash Flow Q1 2026
-$9.07B
Free Cash Flow Q2 2025
-$3.22B
Free Cash Flow Q1 2025
-$3.41B
CapEx Q2 2026
-$19.24B
CapEx Q1 2026
-$10.11B
CapEx Q2 2025
-$2.85B
CapEx Q1 2025
-$4.14B
D&A Q2 2026
$2.85B
D&A Q2 2025
$1.53B
Stock-Based Compensation Q2 2026
$831M
Stock-Based Compensation Q2 2025
$462M
Financing Cash Flow Q2 2026
+$93.17B
Ending Cash Q2 2026
$94.35B
Net Income TTM
-$8.89B
Debt/Equity
31.2x
Strengths
Concerns
SPCX is a high-conviction, high-multiple growth story at an inflection point with a $1.865T market cap. Fundamentals are improving rapidly with revenue acceleration to $7.81B (+91.9% YoY), gross margins of 55.3%, and operating cash flow turning positive at $2.42B. The balance sheet has been substantially strengthened by a recent $85.68B equity raise, leaving a fortress $93.52B cash position. However, technicals are weak (below both MAs), the forward P/E of 88.4x demands flawless execution, free cash flow remains deeply negative at -$16.82B due to extraordinary CapEx of $19.24B, and the company is still unprofitable on a TTM basis with net income of -$8.89B. This is a stock suitable for long-term investors with high risk tolerance who believe in the commercial space thesis.
Macro: Hawkish macro backdrop with Polymarket pricing 89% (up 3.3pp WoW) odds of no Fed cuts in 2026; gold settling lower on Warsh inflation concerns ahead of Jackson Hole; markets bracing for inflation-forward guidance. Higher-for-longer Fed stance historically compresses long-duration growth multiples, creating headwinds for SPCX as the most duration-sensitive name in public markets.